Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
In t(8;21)(q22;q22) acute myeloid leukemia, the prognostic value of early minimal residual disease assessed with real-time quantitative polymerase chain reaction is the most important prognostic factor, but how long-term minimal residual disease monitoring may contribute to drive individual patient...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ferrata Storti Foundation
2016-03-01
|
| סדרה: | Haematologica |
| גישה מקוונת: | https://haematologica.org/article/view/7651 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
